ResMed (ASX:RMD) share price on watch after beating expectations in FY21

This sleep treatment company was on form again in FY 2021…

| More on:
A man wakes up happy with a smile on his face and arms outstretched.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ResMed Inc (ASX: RMD) share price will be one to watch this morning.

This follows the release of the sleep treatment focused medical device company's full year results.

ResMed share price on watch after beating expectations

  • Revenue increased 8% to US$3.2 billion
  • Non-GAAP operating profit up 12% to US$993.8 million
  • Non-GAAP net income rose 13% to US$780.6 million
  • Earnings per share increased 12% to US$5.33

What happened in FY21 for ResMed?

ResMed was a positive performer in the fourth quarter, outperforming the market's expectations for both revenue and earnings per share. This could bode well for the ResMed share price today.

Pleasingly, it was the same story for the whole of FY 2021, with ResMed delivering solid revenue and profit growth despite cycling a period boosted by COVID-19 ventilator sales.

The company notes that it derived incremental respiratory care revenue from COVID-19 related demand of approximately US$20 million in the fourth quarter. This compares to US$125 million in the prior corresponding period.

ResMed was able to offset this with strong sales from its core business thanks to a recovery in its sleep apnoea and COPD patient flow. This was boosted by a major quality issue from one of its leading competitors.

This led to full year Global Device sales rising 7% to US$1,610 million, Mask sales increasing 11% to US$1,213.2 million, and Software as a Service sales growing 5% to US$373.6 million. Growth was delivered both in the United States market and internationally.

What did management say?

ResMed's CEO, Mick Farrell, was pleased with the company's strong finish to the year.

He commented: "Our fourth quarter and full-year fiscal year 2021 results continue to demonstrate the strength and resiliency of our business. During the quarter, we saw the ongoing recovery of core sleep apnea and COPD patient flow across our business, as healthcare systems continue to adopt new models of patient care. We faced some headwinds this quarter, as we annualized the $125 million in COVID-related ventilator sales from this period in 2020, and we saw some tailwinds from a competitor's major quality issue that was announced during the quarter.

"At this time of incredible demand for ResMed products, we are doing everything we can to increase our manufacturing of sleep and respiratory care devices. Our global team is supporting patients, providers, and physicians with our priority to get products directly into the hands of patients who need therapy most."

What's next for ResMed?

While no guidance was given for the year ahead, management spoke positively about its prospects in FY 2022.

Mr Farrell explained: "Looking ahead, we are confident in our ability to grow steadily through our fiscal year 2022 and to deliver for all our stakeholders. We're driving accelerated adoption of digital health solutions in sleep apnea, COPD, and out-of-hospital care, accelerating our ResMed 2025 strategy. These digital health solutions provide efficiency and lower costs for providers and payers, as well as better quality-of-life and clinical outcomes for patients and physicians, and sustainable growth for all of our ResMed stakeholders."

The ResMed share price is up 35% since the start of the year.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Earnings Results

Man jumps for joy in front of a background of a rising stocks graphic.
Earnings Results

Catapult shines: 20% sales growth propels ASX tech stock to new 52-week high

A strong annual result from this tech player has caught investor attention.

Read more »

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Earnings Results

Xero share price leaps 8% on staggering earnings upheaval

A major turnaround in profitability is sending investors into a frenzy over Xero shares today.

Read more »

a construction worker sits pensively at his desk with his arm propping up his chin as he looks at his laptop computer while wearing a hard hat and visibility vest in a bunker style construction shed.
Materials Shares

Which ASX 200 stock just plunged 12% despite record full-year earnings?

It looks like an impressive report card but UBS doesn't like the FY25 guidance.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Earnings Results

ASX 200 tech stock lifts off on another record-setting half-year profit

Investors are bidding up the ASX 200 tech company following its half-year results.

Read more »

increasing rural asx share price represented by happy looking sheep
Earnings Results

Why is this ASX All Ords stock staying strong as profits crash 76%

How is this company's share price marching higher after mowing down more than three-quarters of its profits compared to a…

Read more »

Two men sit side by side on a couch with video game controls in their hands and expressive looks on their faces as they react to the action in front of them in a home setting.
Earnings Results

Guess which ASX 200 stock is surging 11% on an 'outstanding' result

This ASX gaming giant just posted a 17% jump in profits, and its shareholders are basking in the glory.

Read more »

Agricultural ASX share price on watch represented by farmer in field looking at tablet computer.
Earnings Results

Graincorp share price lifts off as dividend is maintained and debts plunge

ASX 200 investors are bidding up the Graincorp share price today. But why?

Read more »

Smiling elderly couple looking at their superannuation account, symbolising retirement.
Earnings Results

Why is this ASX 200 stock avoiding the market selloff and pushing higher?

Not all shares are falling with the market on Thursday.

Read more »